These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37146415)

  • 1. Nobiletin alleviates myocardial ischemia-reperfusion injury via ferroptosis in rats with type-2 diabetes mellitus.
    Huang Q; Tian L; Zhang Y; Qiu Z; Lei S; Xia ZY
    Biomed Pharmacother; 2023 Jul; 163():114795. PubMed ID: 37146415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting Rev-erbα-mediated ferroptosis alleviates susceptibility to myocardial ischemia-reperfusion injury in type 2 diabetes.
    Huang Q; Tian H; Tian L; Zhao X; Li L; Zhang Y; Qiu Z; Lei S; Xia Z
    Free Radic Biol Med; 2023 Nov; 209(Pt 1):135-150. PubMed ID: 37805047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rev-erbs agonist SR9009 alleviates ischemia-reperfusion injury by heightening endogenous cardioprotection at onset of type-2 diabetes in rats: Down-regulating ferritinophagy/ferroptosis signaling.
    Huang Q; Tian L; Zhao X; Lei S; Zhao B; Qiu Z; Xia ZY
    Biomed Pharmacother; 2022 Oct; 154():113595. PubMed ID: 36029539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shenmai Injection Attenuates Myocardial Ischemia/Reperfusion Injury by Targeting Nrf2/GPX4 Signalling-Mediated Ferroptosis.
    Mei SL; Xia ZY; Qiu Z; Jia YF; Zhou JJ; Zhou B
    Chin J Integr Med; 2022 Nov; 28(11):983-991. PubMed ID: 35997859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
    Xu Y; Li X; Cheng Y; Yang M; Wang R
    FASEB J; 2020 Dec; 34(12):16262-16275. PubMed ID: 33070393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis.
    Xu S; Wu B; Zhong B; Lin L; Ding Y; Jin X; Huang Z; Lin M; Wu H; Xu D
    Bioengineered; 2021 Dec; 12(2):10924-10934. PubMed ID: 34699317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HJ11 decoction restrains development of myocardial ischemia-reperfusion injury in rats by suppressing ACSL4-mediated ferroptosis.
    Zhang F; Li Z; Gao P; Zou J; Cui Y; Qian Y; Gu R; Xu W; Hu J
    Front Pharmacol; 2022; 13():1024292. PubMed ID: 36483736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baicalin Prevents Myocardial Ischemia/Reperfusion Injury Through Inhibiting ACSL4 Mediated Ferroptosis.
    Fan Z; Cai L; Wang S; Wang J; Chen B
    Front Pharmacol; 2021; 12():628988. PubMed ID: 33935719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis Is Involved in Diabetes Myocardial Ischemia/Reperfusion Injury Through Endoplasmic Reticulum Stress.
    Li W; Li W; Leng Y; Xiong Y; Xia Z
    DNA Cell Biol; 2020 Feb; 39(2):210-225. PubMed ID: 31809190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ammidin ameliorates myocardial hypoxia/reoxygenation injury by inhibiting the ACSL4/AMPK/mTOR-mediated ferroptosis pathway.
    Han Y; Yuan H; Li F; Yuan Y; Zheng X; Zhang X; Sun J
    BMC Complement Med Ther; 2023 Dec; 23(1):459. PubMed ID: 38102654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of MALT1 reduces ferroptosis in rat hearts following ischemia/reperfusion via enhancing the Nrf2/SLC7A11 pathway.
    Jiang YQ; Yang XY; Duan DQ; Zhang YY; Li NS; Tang LJ; Peng J; Luo XJ
    Eur J Pharmacol; 2023 Jul; 950():175774. PubMed ID: 37146710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis.
    Li T; Tan Y; Ouyang S; He J; Liu L
    Gene; 2022 Jan; 808():145968. PubMed ID: 34530090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nobiletin suppresses oxidative stress and apoptosis in H9c2 cardiomyocytes following hypoxia/reoxygenation injury.
    Liu F; Zhang H; Li Y; Lu X
    Eur J Pharmacol; 2019 Jul; 854():48-53. PubMed ID: 30951715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gossypol Acetic Acid Attenuates Cardiac Ischemia/Reperfusion Injury in Rats via an Antiferroptotic Mechanism.
    Lin JH; Yang KT; Ting PC; Luo YP; Lin DJ; Wang YS; Chang JC
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis occurs in phase of reperfusion but not ischemia in rat heart following ischemia or ischemia/reperfusion.
    Tang LJ; Luo XJ; Tu H; Chen H; Xiong XM; Li NS; Peng J
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):401-410. PubMed ID: 32621060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Circadian PER2 Enhancer Nobiletin Reverses the Deleterious Effects of Midazolam in Myocardial Ischemia and Reperfusion Injury.
    Oyama Y; Bartman CM; Gile J; Sehrt D; Eckle T
    Curr Pharm Des; 2018; 24(28):3376-3383. PubMed ID: 30246635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative medicine and cellular longevity the role and mechanism of NCOA4 in ferroptosis induced by intestinal ischemia reperfusion.
    Li K; Wang A; Diao Y; Fan S
    Int Immunopharmacol; 2024 May; 133():112155. PubMed ID: 38688134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Puerarin Protects against Myocardial Ischemia/Reperfusion Injury by Inhibiting Ferroptosis.
    Ding Y; Li W; Peng S; Zhou G; Chen S; Wei Y; Xu J; Gu H; Li J; Liu S; Liu B
    Biol Pharm Bull; 2023 Apr; 46(4):524-532. PubMed ID: 36696989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxysafflor Yellow A Alleviates Acute Myocardial Ischemia/Reperfusion Injury in Mice by Inhibiting Ferroptosis via the Activation of the HIF-1α/SLC7A11/GPX4 Signaling Pathway.
    Ge C; Peng Y; Li J; Wang L; Zhu X; Wang N; Yang D; Zhou X; Chang D
    Nutrients; 2023 Jul; 15(15):. PubMed ID: 37571350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4
    Tao WH; Shan XS; Zhang JX; Liu HY; Wang BY; Wei X; Zhang M; Peng K; Ding J; Xu SX; Li LG; Hu JK; Meng XW; Ji FH
    Front Pharmacol; 2022; 13():782466. PubMed ID: 35873574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.